- Home
- PRAX vs RSVR Comparison
PRAX vs RSVR Comparison
Compare PRAX & RSVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- RSVR
- Stock Information
- Founded
- PRAX 2015
- RSVR 2007
- Country
- PRAX United States
- RSVR United States
- Employees
- PRAX N/A
- RSVR N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- RSVR Movies/Entertainment
- Sector
- PRAX Health Care
- RSVR Consumer Discretionary
- Exchange
- PRAX Nasdaq
- RSVR Nasdaq
- Market Cap
- PRAX 599.7M
- RSVR 528.3M
- IPO Year
- PRAX 2020
- RSVR N/A
- Fundamental
- Price
- PRAX $38.35
- RSVR $7.20
- Analyst Decision
- PRAX Strong Buy
- RSVR Strong Buy
- Analyst Count
- PRAX 10
- RSVR 1
- Target Price
- PRAX $116.50
- RSVR $12.50
- AVG Volume (30 Days)
- PRAX 430.8K
- RSVR 38.7K
- Earning Date
- PRAX 05-02-2025
- RSVR 05-29-2025
- Dividend Yield
- PRAX N/A
- RSVR N/A
- EPS Growth
- PRAX N/A
- RSVR 4113.60
- EPS
- PRAX N/A
- RSVR 0.12
- Revenue
- PRAX $8,122,000.00
- RSVR $156,433,584.00
- Revenue This Year
- PRAX N/A
- RSVR $10.97
- Revenue Next Year
- PRAX $789.73
- RSVR $6.81
- P/E Ratio
- PRAX N/A
- RSVR $60.53
- Revenue Growth
- PRAX 270.02
- RSVR 11.32
- 52 Week Low
- PRAX $26.70
- RSVR $6.56
- 52 Week High
- PRAX $91.83
- RSVR $9.83
- Technical
- Relative Strength Index (RSI)
- PRAX 53.31
- RSVR 47.39
- Support Level
- PRAX $34.89
- RSVR $7.11
- Resistance Level
- PRAX $40.89
- RSVR $7.48
- Average True Range (ATR)
- PRAX 2.30
- RSVR 0.32
- MACD
- PRAX 0.70
- RSVR 0.02
- Stochastic Oscillator
- PRAX 57.95
- RSVR 45.52
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. The company's segment includes Music Publishing; Recorded Music and others. It generates the maximum of its revenue from the Music Publishing segment.